Business
Notice of Allowance for Mexican patent
Notice of Allowance for Mexican patent.
About this update from Eden Research Plc
[{"type":"text","content":"\n \nRNS Number : 1492H Eden Research plc 15 May 2014 \n \n\n \nEden Research Plc\n(\"Eden\" or \"Company\")\n \nNotice of Allowance for Mexican patent\n \nEden Research plc (AIM: EDEN), the AIM listed natural micro-encapsulation company, announces that the Mexican Industrial Property Institute (IMPI) has issued a Notice of Allowance for its patent regarding the treatment of mites.\n \nThe patent covers the Company's core technology, specifically \"a method of killing mites, said method comprising the step of administering to said mites in an effective dose a composition comprising a hollow glucan or cell wall particle encapsulating a terpene component wherein the terpene component comprises citral alone or a combination of eugenol, thymol and citral.\"\n \nClive Newitt, Managing Director of Eden comments: \"We are delighted to announce this Notice of Allowance from IMPI as it strengthens Eden's intellectual property portfolio further and provides additional geographic protection for the use of technology in commercial application for the treatment of mites. This supports our strategy to exploit additional market sectors using Eden's encapsulation technology and brings the total number of granted patents to 45. \"\n \n \n\n\n\n\nEden Research plc \n\n\nwww.edenresearch.com\n\n\n\n\nClive Newitt, Managing Director\n\n\nTel: 01993 862 761\n\n\n\n\nAlex Abrey, Chief Financial Officer\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nW H Ireland Limited \n\n\nTel: 0117 945 3471\n\n\n\n\nJohn Wakefield\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR Ltd\n\n\nTel: 020 7933 8780 or [email protected]\n\n\n\n\nPaul McManus\n\n\nMob: 07980 541 893 \n\n\n\n\n\n\n \nNotes:\n \nEden is an early stage revenue company with intellectual property and expertise in encapsulation, terpenes and environmentally friendly technologies to provide naturally occurring solutions to the global agrochemicals industry, the animal health industry, and consumer products. \n \nEden's encapsulation technology harnesses the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with hydrophobic compounds both natural and synthetic. The technology uses yeast cells to deliver a slow release of nat...